Effect of vitamin C supplements on patients with hypertension

Author(s):
SH RavanshadSH Ravanshad,*, SH SadeghiSH Sadeghi, MJ . ZibaeinejadMJ . Zibaeinejad, E Setoudeh  MaramE Setoudeh Maram, H MontaseriH Montaseri
*Corresponding Author: Email: [email protected]

Journal of Inflammatory Diseases:Vol. 9, issue 2; 94-98
Published online:Sep 30, 2005
Article type:Research Article
How to Cite:Ravanshad S, Sadeghi S, . Zibaeinejad M, Setoudeh Maram E, Montaseri H. Effect of vitamin C supplements on patients with hypertension. J Inflamm Dis. 2024;9(2):e155133. doi:

Abstract

¯Abstract Background: High blood pressure is among the established risk factor for cardiovascular disease. Vitamin C may modulate other established risk factors and processes, thereby reducing the risk of overt disease. Objective: To investigate the relationship between antioxidant vitamin C supplementation and blood pressure level in hypertensive subjects. Methods: In an experimental study (before and after study) we selected 35 hypertensive patients. Anthropometric indices were measured and BMI was calculated. Fasting blood samples were collected before and after the one-month administration of 500mg vitamin C/day. Plasma vitamin C concentration was measured using 2, 4 dinitrophenyl hydrazine and UV/vis spectrophotometer. Blood pressure was measured by 24 hr holter monitoring. A mean 3-day food records and food frequency questionnaire was analyzed by Nutrition III soft ware. Findings: The results indicated that following the one-month consumption of 500mg vitamin C/day, both SBP (p< 0.005) and DBP (p<0.003) were significantly decreased. At the same time, plasma ascorbic acid concentration showed a significant increase (p<0.005). There was an inverse correlation between the change in SBP and the change in ascorbic acid concentration (p<0.006). Conclusion: The data suggested that the consumption of 500mg ascorbic acid/day reduces both SBP and DBP in hypertensive subjects.

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Mar
2009

Modulation of Blood Pressure in Hypertensive Patients by Vitamin C

Mohammad Javad Zibaeenezhad,
Mohammad Hassan Eftekhari,
Kamran Aghasadeghi

Zibaeenezhad MJ, Eftekhari MH, Aghasadeghi K. Modulation of Blood Pressure in Hypertensive Patients by Vitamin C. Int Cardiovasc Res J. 2009;3(1):e68525. doi:

20
Jun
2007

The Effect of Vitamin E Supplementation on Mild Hypertension

M Boshtam‎,
M Rafiei,
K Sadeghi,
N Sarraf-Zadegan

Boshtam‎ M, Rafiei M, Sadeghi K, Sarraf-Zadegan N. The Effect of Vitamin E Supplementation on Mild Hypertension. J Kermanshah Univ Med Sci. 2007;11(1):e80904. doi:

30
Jun
2006

The effect of ascorbic acid on serum level of copper, zinc, ceruloplasmin enzyme activity and iron parameters in men

M Tofighi,
A Aminpour,
M Kimiagar,
B. Gloestaan

Tofighi M, Aminpour A, Kimiagar M, Gloestaan B. The effect of ascorbic acid on serum level of copper, zinc, ceruloplasmin enzyme activity and iron parameters in men. J Inflamm Dis. 2024;10(1):e155185. doi:

25
Feb
2015

Effects of oral vitamin C supplement on the serum lipid profile

Mojgan Mohajeri-Iravani,
Ebrahim Hazrati,
Shahram Firuz-Marani Firuz-Marani

Mohajeri-Iravani M, Hazrati E, Firuz-Marani SF. Effects of oral vitamin C supplement on the serum lipid profile. Ann Mil Health Sci Res. 2015;13(1):e62671. doi:

27
Nov
2013

Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study

Vajihe Biniaz,
Mehdi Sadeghi Shermeh,
Abbas Ebadi,
Ali Tayebi,
Behzad Einollahi

Biniaz V, Sadeghi Shermeh M, Ebadi A, Tayebi A, Einollahi B. Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study. Nephro-Urol Mon. 2013;6(1):e13351. doi: https://doi.org/10.5812/numonthly.13351

Download PDF179.15 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles